PRTA - Prothena Corporation plc

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
53,905
53,905
200,577
853
814
Operating expenses
Research development
135,562
135,562
82,284
74,884
50,836
Selling general and administrative
49,900
49,900
46,318
38,703
35,736
Total operating expenses
185,462
185,462
128,602
113,587
86,572
Operating income or loss
-131,557
-131,557
71,975
-112,734
-85,758
Interest expense
0
-
-
-
0
Total other income/expenses net
-397
5,952
-54
1,307
8,460
Income before tax
-125,605
-125,605
71,921
-111,427
-77,298
Income tax expense
-8,656
-8,656
4,946
-283
379
Income from continuing operations
-116,949
-116,949
66,975
-111,144
-77,677
Net income
-116,949
-116,949
66,975
-111,144
-77,677
Net income available to common shareholders
-116,949
-116,949
66,975
-111,144
-77,677
Basic EPS
-
-2.47
1.51
-2.78
-1.95
Diluted EPS
-
-2.47
1.38
-2.78
-1.95
Basic average shares
-
47,369
44,228
39,915
39,882
Diluted average shares
-
47,369
48,464
39,915
39,882
EBITDA
-
-131,557
71,975
-112,734
-85,758